165 results
Page 3 of 9
8-K
EX-99.2
e10dcl16v6g
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
bf77yc6p1cwue
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
opwczz7ot4
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
pwdltq7vsy18
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
a84z 3eq0tdgknj44hxj
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
voa2uu8ln32p
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
5lk7 jhne
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.1
3nf m4tbstxd
14 Feb 22
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
12:00am
8-K
EX-99.2
ity2rwhkzluz6h0w0
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.1
07f rnwkccd9
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.2
h9im8j wvro
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
2x3 oo4pqvfn6rzft3
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
x7vbn gxr8m
14 Jun 21
Other Events
5:21pm
8-K
EX-99.1
p0n22x8x06
26 May 21
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing
10:17am